isavuconazole
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics of Isavuconazole
Conditions
Pharmacokinetics of Isavuconazole, Healthy Volunteers, Renal Impaired
Trial Timeline
Mar 1, 2012 → Apr 1, 2013
NCT ID
NCT01555866About isavuconazole
isavuconazole is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics of Isavuconazole. The current trial status is completed. This product is registered under clinical trial identifier NCT01555866. Target conditions include Pharmacokinetics of Isavuconazole, Healthy Volunteers, Renal Impaired.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics of Isavuconazole were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03149055 | Phase 2 | Completed |
| NCT01657890 | Phase 1 | Completed |
| NCT01555866 | Phase 1 | Completed |
| NCT00634049 | Phase 3 | Completed |
Competing Products
20 competing products in Pharmacokinetics of Isavuconazole